Rare diseases
Investigational molecules
Locations
Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO
AustriaLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
AustriaStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
AustriaStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
AustriaStudy on the Safety of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
AustriaStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
AustriaStudy on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy
AustriaStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
AustriaStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
AustriaStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
AustriaStudy on Testosterone Undecanoate Effects on Liver Fat in Obese Men with Low Testosterone and Type 2 Diabetes or Prediabetes
AustriaStudy of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
